| Project | Entity | Impact | Status |
|---|---|---|---|
| Critical | |||
Lotus's FM Contract Retention |
PT | ฿3.8M/month retainer = PT primary revenue anchor |
At risk |
| Strategic | |||
ReGen Capital EOI |
ID | ฿24M–฿49M implied equity (4–8× EBITDA) |
DD-Prep |
Cleantopia M&A (STIC) |
ID | ฿250M for 49% ID → clears all debt + recapitalises group |
Stalled |
| High | |||
PT War Pricing v2.0 (+25%) |
PT | +25% margin across 259 SKUs. Compounds annually. |
Live Apr 1 2026 |
Hospital Price Renegotiations |
ID | ฿11.9M underbilling gap — recoverable |
Active, no timeline |
| Personal | |||
AIA Insurance Advisory |
Personal | 4 leads · ฿45–90K FYC per HNW · renewal book ฿150–400K/mo |
Closing now |
| P1T | |||
Sansiri Executive Calibration |
P1T | Active. Likely ฿50–200K. |
Active |
P1T AI Advisory (Bright / K Garden) |
P1T | ฿80–150K. Validates methodology + price anchor. |
Scoping |
| Ops | |||
PT CRM Build (M1+M2) |
PT | Enables PT freelance sales programme |
M1 live · M2 June |
| Structural | |||
PT Separation Pipeline |
PT | Structural independence. Reduces cross-entity liability. |
Active priority |